• Trials and Research

  Phase 3 Trials of Oral Evobrutinib in Relapsing MS Patients Opening Soon, MD Serono Says

  Posted by MS News Today Moderator on October 2, 2019 at 8:33 am

  

  EMD Serono is opening two pivotal and global Phase 3 clinical trials testing oral evobrutinib against Avonex injections in RRMS and SPMS with relapses. Read more about the projects here.

  What do you think of this news?

  replied 4 years, 6 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply